In silico insights into the identification of potential novel angiogenic inhibitors against human VEGFR-2: a new SAR-based hierarchical clustering approach

References

• Gavalas NG, Liontos M, Trachana SP, et al. Angiogenesis-related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci. 2013;14:15885–15909.
   PubMed Web of Science ®Google Scholar
• Bielenberg DR, Zetter BR. The contribution of angiogenesis to the process of metastasis. Cancer J. 2015;21:267–273.
   PubMed Web of Science ®Google Scholar
• Serova M, Ghoul A, Benhadji KA, et al. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells. Mol Cancer Ther. 2008;7:915–922.
   PubMed Web of Science ®Google Scholar
• Luangdilok S, Box C, Harrington K, et al. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur J Cancer. 2011;47:520–529.
   PubMed Web of Science ®Google Scholar
• Sonthithai P, Suriyo T, Thiantanawat A, et al. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells. J Appl Toxicol. 2016;36:790–801.
   PubMed Web of Science ®Google Scholar
• Musumeci F, Radi M, Brullo C, et al. Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors. J Med Chem. 2012;55:10797–10822.
   PubMed Web of Science ®Google Scholar
• Loges S, Schmidt T, Carmeliet P. Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer. 2010;1:12–25.
   PubMedGoogle Scholar
• Bommu UD, Konidala KK, Pamanji R, et al. Structural probing, screening and structure-based drug repositioning insights into the identification of potential Cox-2 inhibitors from selective coxibs. Interdiscip Sci. 2017; doi:10.1007/s12539-017-0244-5.
   PubMedGoogle Scholar
• Bommu UD, Konidala KK, Pamanji R, et al. Computational screening, ensemble docking and pharmacophore analysis of potential gefitinib analogues against epidermal growth factor receptor. J Recept Signal Transduct Res. 2018;38:48–60.
   PubMed Web of Science ®Google Scholar
• Sliwoski G, Kothiwale S, Meiler J, et al. Computational methods in drug discovery. Pharmacol Rev. 2014;66:334–395.
   PubMed Web of Science ®Google Scholar
• Anderson AC. Structure-based functional design of drugs: from target to lead compound. Methods Mol Biol. 2012;823:359–366.
   PubMedGoogle Scholar
• Lionta E, Spyrou G, Vassilatis D, et al. Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem. 2014;14:1923–1938.
   PubMed Web of Science ®Google Scholar
• Oguro Y, Miyamoto N, Okada K, et al. Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem. 2010;18:7260–7273.
   PubMed Web of Science ®Google Scholar
• Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779–815.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Macarthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291.
   Web of Science ®Google Scholar
• Lüthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356:83–85.
   PubMed Web of Science ®Google Scholar
• Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35:W407–W410.
   PubMed Web of Science ®Google Scholar
• Zoete V, Cuendet MA, Grosdidier A, et al. SwissParam: A fast force field generation tool for small organic molecules. J Comput Chem. 2011;32:2359–2368.
   PubMed Web of Science ®Google Scholar
• Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–250.
   PubMedGoogle Scholar
• Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2005;45:160–169.
   PubMed Web of Science ®Google Scholar
• Kumar KK, Devi BU, Neeraja P. Integration of in silico approaches to determination of endocrine-disrupting perfluorinated chemicals binding potency with steroidogenic acute regulatory protein. Biochem Biophys Res Commun. 2017;491:1007–1014.
   PubMed Web of Science ®Google Scholar
• Kim S, Han L, Yu B, et al. PubChem structure–activity relationship (SAR) clusters. J Cheminform. 2015;7:33.
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Roth BL, Armbruster BN, et al. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25:197–206.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
   PubMed Web of Science ®Google Scholar
• Bommu UD, Konidala KK, Pabbaraju N, et al. Ligand-based virtual screening, molecular docking, QSAR and pharmacophore analysis of quercetin-associated potential novel analogs against epidermal growth factor receptor. J Recept Signal Transduct Res. 2017;37:600–610.
   PubMed Web of Science ®Google Scholar
• Elokely KM, Doerksen RJ. Docking challenge: protein sampling and molecular docking performance. J Chem Inf Model. 2013;53:1934–1945.
   PubMed Web of Science ®Google Scholar
• Lee GR, Seok C. Galaxy7TM: flexible GPCR–ligand docking by structure refinement. Nucleic Acids Res 2016;44(W1):W502–W506.
   PubMed Web of Science ®Google Scholar
• Kumar S, Tsai CJ, Ma B, et al. Contribution of salt bridges toward protein thermostability. J Biomol Struct Dyn. 2000;17:79–85.
   PubMed Web of Science ®Google Scholar
• Xie NZ, Du QS, Li JX, et al. Exploring strong interactions in proteins with quantum chemistry and examples of their applications in drug design. PLoS One. 2015;10:e0137113.
   PubMed Web of Science ®Google Scholar